Acquired von willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device

JACC: Heart Failure

Volumn 2, Issue 2, 2014, Pages 141-145

  Meyer, Anna L ^a   Malehsa, Doris ^b   Budde, Ulrich ^c   Bara, Christoph ^b   Haverich, Axel ^b   Strueber, Martin ^a  

^a UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Aesculabor Hamburg GmbH   (Germany)

Author keywords

Bleeding; HeartMate II; HeartWare; LVAD; Von Willebrand syndrome

Indexed keywords

C REACTIVE PROTEIN; VON WILLEBRAND FACTOR; ANTICOAGULANT AGENT; POLYMER;

ADULT; ARTICLE; BLEEDING; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CONTROLLED STUDY; DEVICE SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; THROMBOEMBOLISM; VON WILLEBRAND DISEASE; ADVERSE EFFECTS; COMPLICATION; HEART ASSIST DEVICE; HEART FAILURE; HEMORRHAGE; HEMOSTASIS; METABOLISM; MIDDLE AGED; PROSTHESIS; REOPERATION; ACQUIRED VON WILLEBRAND SYNDROME; AGE; AXIAL CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; BLOOD GROUP; CELL INTERACTION; CENTRIFUGAL CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; IMPLANTATION; LEFT VENTRICULAR ASSIST DEVICE; MORBIDITY; THROMBOCYTE;

ANTICOAGULANTS; C-REACTIVE PROTEIN; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HEMORRHAGE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PROSTHESIS DESIGN; REOPERATION; RETROSPECTIVE STUDIES; THROMBOEMBOLISM; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 84897485515     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2013.10.008     Document Type: Article

References (18)

1. Wieselthaler G.M., O Driscoll G., Jansz P., Khaghani A., Strueber M. Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial. JHeart Lung Transplant 2010, 29:1218-1225. HVAD Clinical Investigators.
2. Starling R.C., Naka Y., Boyle A.J., et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). JAm Coll Cardiol 2011, 57:1890-1898.
3. Lahpor J., Khaghani A., Hetzer R., et al. European results with a continuous-flow ventricular assist device for advanced heart-failure patients. Eur J Cardiothorac Surg 2010, 37:357-361.
4. Demirozu Z.T., Radovancevic R., Hochman L.F., et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. JHeart Lung Transplant 2011, 30:849-853.
5. Stern D.R., Kazam J., Edwards P., et al. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD. JCard Surg 2010, 25:352-356.
6. Meyer A.L., Malehsa D., Bara C., et al. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail 2010, 3:675-681.
7. Crow S., Chen D., Milano C., et al. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg 2010, 90:1263-1269. discussion 1269.
8. Geisen U., Heilmann C., Beyersdorf F., et al. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg 2008, 33:679-684.
9. Pareti F.I., Lattuada A., Bressi C., et al. Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation 2000, 102:1290-1295.
10. Tsai H.M., Sussman I.I., Nagel R.L. Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood 1994, 83:2171-2179.
11. Vincentelli A., Susen S., Le Tourneau T., et al. Acquired von Willebrand syndrome in aortic stenosis. NEngl J Med 2003, 349:343-349.
12. Mizunuma H., Nakajima R. Experimental study on shear stress distributions in a centrifugal blood pump. Artif Organs 2007, 31:550-559.
13. Zhang T., Taskin M.E., Fang H.B., et al. Study of flow-induced hemolysis using novel Couette-type blood-shearing devices. Artif Organs 2011, 35:1180-1186.
14. Bockmeyer C.L., Reuken P.A., Simon T.P., et al. ADAMTS13 activity isdecreased in a septic porcine model. Significance for glomerular thrombus deposition. Thromb Haemost 2011, 105:145-153.
15. Gill J.C., Endres-Brooks J., Bauer P.J., Marks W.J., Montgomery R.R. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987, 69:1691-1695.
16. Strueber M., O'Driscoll G., Jansz P., Khaghani A., Levy W.C., Wieselthaler G.M. Multicenter evaluation of an intrapericardial left ventricular assist system. JAm Coll Cardiol 2011, 57:1375-1382.
17. Aaronson K.D., Slaughter M.S., Miller L.W., et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 2012, 125:3191-3200.
18. Zapanta C.M., Griffith J.W., Hess G.D., et al. Microtextured materials for circulatory support devices: preliminary studies. ASAIO J 2006, 52:17-23.